What is Nicotine Replacement Therapy (NRT)?

The realization of the harmfulness of tobacco smoke led to the development of different methods and strategies. The goal was to either make smoking less harmful or facilitate quitting. These efforts began in the mid-20^th century, but the results were often discouraging. That’s until Nicotine Replacement Therapy (NRT) stepped into the spotlight. 

Nicotine replacement therapy revolutionized the whole approach to quitting. At the time, it was a truly groundbreaking solution that offered smokers a much safer alternative to tobacco smoke while attending to their nicotine addiction. Of course, the NRTs were not a one-size-fits-all solution, many individuals continued to struggle with quitting. However, the method opened up a new promising perspective. This article tells the story.

The History

Tobacco smoke is addictive. This is a science-backed fact today, but, in a way, people always knew this. However, it was not until the 1960s that researchers were able to fully understand the complex relationship between nicotine (the addictive component of tobacco) and the brain. Once they knew how nicotine causes the pleasurable sensation by triggering a dopamine release in the brain, the road towards nicotine replacement therapy was paved.

Scientists now knew that if they could provide a nicotine dose in a controlled way, they could alleviate the withdrawal symptoms in smokers who are trying to quit. So, they needed a “vehicle” to deliver only nicotine without the other health-hazardous components of tobacco smoke. The result was the first NRT product, the nicotine gum.

The nicotine gum was developed in Sweden and became available in the 1970s. This new product enabled the users to absorb the desired nicotine dose through the mucous membranes in the mouth, a much safer way to maintain nicotine addiction.

Following the success of the nicotine gum, other NRT products started to emerge. Nicotine patches appeared on the market in the early 1980s. These enabled a steady supply of nicotine through the skin and eliminated the need for frequent dosing. Later on, even more NRT products became available, including inhalers, nasal sprays, lozenges, and microtabs. 

The first NRT products were not without flaws. They were criticized for side effects and limited efficacy (did not work for everyone). For example, the first nicotine gums sometimes could cause mouth irritation, and skin reactions could occur with nicotine patches. Over the years, however, the formulations and delivery methods became more advanced. Today, NRTs fall into the group of safest and most effective aids for smoking cessation.

The Science Behind NRTs

The physical nicotine dependence is the biggest barrier to quitting! When nicotine from tobacco smoke reaches the brain, it creates an intense and rapid sense of pleasure. This quick delivery is the key issue. It strengthens the addiction, making it very difficult to quit. That is why nicotine replacement therapy is designed to provide a slow and steady supply of nicotine and keep the withdrawal symptoms at a minimum. Here’s how different NRT products work:

Nicotine Pouches

They are a modern and smoke-free NRT option. These small pouches, placed between the gum and lip, deliver nicotine through the oral mucosa. They come in various strengths and flavors, providing a flexible and discreet way to manage cravings. Unlike gum or lozenges, nicotine pouches do not require chewing or dissolving, making them an easy-to-use alternative for those looking to quit smoking.

Nicotine Patches

When a patch is applied to the skin, it delivers a steady dose of nicotine for up to 24 hours. The constant supply reduces the withdrawal symptoms and cravings by stabilizing nicotine levels in the bloodstream. Their once-a-day application method makes nicotine patches suitable for individuals who do not want to make quitting smoking a chore.

Nicotine Gum

For acute cravings, chewing nicotine gum can be a quick-fix solution. It delivers nicotine faster than patches, but can also be held between gums and cheek for a steady supply of nicotine. Nicotine gum also comes in different strengths. Everything above makes them a great fit for those looking for more flexibility and quicker absorption. 

Nicotine Lozenge

Nicotine lozenges were designed for individuals who want all the benefits of nicotine gum, without chewing. Lozenges are also absorbed through the mucous membranes in the mouth. They dissolve slowly, providing a steady supply of nicotine.

Nasal Sprays and Nicotine Inhalers

Nicotine inhalers and nasal sprays work even faster than gum. Their rapid delivery of nicotine is comparable to cigarettes. However, these products require frequent dosing and are more suitable for heavy smokers who need an almost instant “hit” to manage cravings and withdrawal symptoms.

Combination Therapies

Some studies suggest that combining different NRT methods can maximize the chances of successful quitting. A combination of nicotine patches and gum is a good example of this. This way, a steady supply of nicotine through nicotine patches is complemented with a quick “fix” with nicotine gum when acute cravings are present. So, smokers stand a better chance of addressing both, the physical and psychological (habit) aspects of addiction. 

How did NRT change over time?

It is safe to say that NRT products were the first, fairly effective, solutions for tobacco addiction. The fact that they are still here proves their efficacy. That’s not all. Through constant innovation, they got better over time. Here’s why:

Improved Formulations

Early NRT formulations faced certain problems. For example, nicotine gum was known to irritate the mucosa in the mouth due to non-optimal pH levels. This is something that does not happen with newer, oral, NRTs. Modern nicotine patches are also available in various sizes and strengths, allowing a more personalized experience.

Tailored Approach

We all have different needs, in many aspects. Smokers are not an exception. For example, not everyone has the same nicotine dependence. Individuals also have varying personal preferences, and smoking habits differ too. That made the NRT manufacturers realize they needed to create a whole range of delivery methods and nicotine strengths to cover the needs of a wider consumer base. 

Working Together with Behavioral Support

Various support methods have proven their effectiveness in alleviating quitting. These include counseling, digital support platforms, quitlines, etc. Behavioral support also complements NRT. Such an integrated approach to quitting addresses all aspects of addiction and can greatly enhance quit rates.

The Impact of NRT on Quitting

As we’ve mentioned earlier, nicotine replacement therapy was the first method with respectable results since major efforts to reduce the number of smokers began. NRT products first became available more than forty years ago. Therefore, there’s been plenty of time for scientific research about its effectiveness. So far, the data indicates positive findings, and millions of NRT product users, all over the world, would probably agree. 

Effectiveness

Over the years, the results of numerous studies have supported nicotine replacement therapy. The findings consistently show that NRT can increase the chances of quitting by as high as 70%. This is not a straightforward process, of course. The results vary from one individual to another and depend on different factors, such as the duration of treatment, the type of product used, and the availability of support. A great example of this is a combination of behavioral support (e.g., counseling) and NRT which, as studies show, can further improve quit rates. 

Public Health Impact

Although we cannot say that nicotine replacement therapy had the same impact on smoking as the asteroid had on the dinosaurs, it was a huge breakthrough in addiction treatment. The positive effect on public health was visible fast and it only grew over time. This is especially visible in the reduction of smoking-related illnesses, such as lung cancer, chronic obstructive pulmonary disease (COPD), and heart disease. As a safer alternative to cigarettes, NRT has also benefited non-smokers. It helped the decline of second-hand smoke exposure. 

Economic Impact

Negative or positive, the economic impact is always there. With NRT the story is a bit complex but noteworthy. In the beginning, the cost of NRT products can be higher, compared to cigarettes (it usually is). This is a short-term view. In the long run, however, NRT generates savings by enabling longer productivity and cutting healthcare costs. Government and healthcare systems often subsidy NRT products and make them available over-the-counter. That’s usually because they’ve recognized the strategy’s long-term cost-effectiveness.

A Conservative Overview of NRT Effectiveness

In the words of a famous American writer Mark Twain, “Giving up smoking is the easiest thing in the world. I know because I’ve done it thousands of times.” – This is an amusing quote that shows people understood the risk of relapse with tobacco addiction way before they knew much about nicotine and the harms of smoking. 

In other words, it is hard to quit smoking for good. Many factors, such as the level of nicotine dependence, motivation, and adherence to the treatment regimen influence the process. That’s why we should also take a more balanced look at everything that affects the effectiveness of nicotine replacement therapy.

Success Rates

A complex process like quitting often requires more than one attempt and several changes of tactics. First, we should state that, in some cases, NRT does not help at all. In others, it can be a partial success. That can mean a significant reduction in smoking or a relapse after a period of abstinence. 

Side Effects

Modern NRT products are well-tolerated, in general. However, side effects are always possible. Some users can experience headaches, nausea, dizziness, or skin irritation (nicotine patches). Whatever the presentation, NRT-related side effects are usually temporary and mild. Still, in some cases, they can be an unpassable obstacle. 

Psychological Dependence

Nicotine replacement therapy is a less harmful way to get the much-needed dose of the addictive agent (nicotine). That is all. Its effects are limited to the physical aspect of dependence, such as cravings and withdrawal symptoms. With this taken care of, the psychological side of addiction remains. In some individuals, psychology can play a key role in addiction. 

The emotional and behavioral associations with smoking can be strong. For some people it’s just holding a cigarette, for others it is drinking coffee and smoking, or smoking after meals and during stress. Whatever the cause, these psychological factors cannot be addressed by NRT. They require additional support, such as behavioral therapy or counseling.

Alternatives

NRT is not the only way to fight tobacco addiction. For many, it is not the preferred way either. There are other methods, such as prescription medications (e.g., bupropion, varenicline). There is also hypnosis, acupuncture, and other non-nicotine approaches. Quitting is a personal journey and not an easy one. Some people find it easier to take the alternative route. For them, it may work better. That’s why it is essential to consider an entire range of available options when designing a quit plan.

The Bottom Line

The world was very much a different place back when nicotine replacement therapy first became available. Since then, the popular quitting method has come a long way to include the variety of cessation tools we know today. From the first introduction of nicotine gum to the invention of nicotine patches, lozenges, nasal sprays, and inhalers, the story of nicotine replacement therapy was one of technological advances. More importantly, it was a story of improved public health and economic benefits.

However, we cannot look at the effectiveness of NRT with a bias. After all, its effectiveness is not universal and calls for a balanced view. On one hand, the NRT’s potential is undebatable. It is a powerful and potentially highly effective quitting tool. On the other hand, to unlock all that potential, NRT requires a comprehensive cessation plan that includes other components too, such as behavioral support to address the psychological aspects of addiction. Accessibility, in every sense, also remains a concern.

The bottom line is that nicotine replacement therapy is a key moment in the battle against tobacco addiction. But it is an ongoing battle. It is far from over and it will certainly take a wider understanding of the science, history, public health impact, etc., to formulate new, successful, complementary, and personalized strategies. A major role of NRT in these is guaranteed, with a final goal of achieving a smoke-free world. 

References:

• • O’Connor, R., Schneller, L. M., Felicione, N. J., Talhout, R., Goniewicz, M. L., & Ashley, D. L. (2022). Evolution of tobacco products: recent history and future directions. Tobacco control, 31(2), 175-182.

• • Willoughby, E. A., Giannelis, A., Iacono, W. G., McGue, M., & Vrieze, S. I. (2022). A Century of Behavioral Genetics at the University of Minnesota. Twin Research and Human Genetics, 25(6), 211-225.

• • DiSilvio, B., Baqdunes, M., Alhajhusain, A., & Cheema, T. (2021). Smoking addiction and strategies for cessation. Critical Care Nursing Quarterly, 44(1), 33-48.

• • Elam, M. (2014). The technopolitics of nicotine replacement from Nicorette® gum to e-cigarettes. In The elementary forms of sociological knowledge: Essays in honour of Margareta Bertilsson. University of Copenhagen, Copenhagen.

• • Pastore, M. N., Kalia, Y. N., Horstmann, M., & Roberts, M. S. (2015). Transdermal patches: history, development and pharmacology. British journal of pharmacology, 172(9), 2179-2209.

• • Jarvik, M. E. (2017). The role of nicotine in the smoking habit. In Learning mechanisms in smoking (pp. 155-190). Routledge.

• • West, R., Hajek, P., Nilsson, F., Foulds, J., May, S., & Meadows, A. (2001). Individual differences in preferences for and responses to four nicotine replacement products. Psychopharmacology, 153, 225-230.

• • Szubin, A. (1998). Levelling the Playing Field: the FDA’s Regulation of Nicotine Dependence Products. Food & Drug.

• • Shiffman, S. (2007). Use of more nicotine lozenges leads to better success in quitting smoking. Addiction, 102(5), 809-814.

• • Schneider, N. G., Olmstead, R. E., Franzon, M. A., & Lunell, E. (2001). The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clinical pharmacokinetics, 40, 661-684.

• • Sweeney, C. T., Fant, R. V., Fagerstrom, K. O., McGovern, J. F., & Henningfield, J. E. (2001). Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS drugs, 15, 453-467.

• • Okeke, O. C. (2017). Formulation of novel buccal mucosal drug delivery systems for nicotine replacement therapy (NRT) (Doctoral dissertation, University of Greenwich).

• • McClure, J. B., & Swan, G. E. (2006). Tailoring nicotine replacement therapy: rationale and potential approaches. CNS drugs, 20, 281-291.

• • Davis, K. A., Coady, M. H., Mbamalu, I. G., Sacks, R., & Kilgore, E. A. (2013). Lessons learned from the implementation of a time-limited, large-scale nicotine replacement therapy giveaway program in New York City. Health promotion practice, 14(5), 767-776.

• • Ellerbeck, E. F., Nollen, N., Hutcheson, T. D., Phadnis, M., Fitzgerald, S. A., Vacek, J., … & Richter, K. P. (2018). Effect of long-term nicotine replacement therapy vs standard smoking cessation for smokers with chronic lung disease: a randomized clinical trial. JAMA network open, 1(5), e181843-e181843.

• • Etter, J. F., & Stapleton, J. A. (2006). Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tobacco control, 15(4), 280-285.

• • Mills, E. J., Wu, P., Lockhart, I., Wilson, K., & Ebbert, J. O. (2010). Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tobacco Induced Diseases, 8, 1-15.

• • Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., … & Evins, A. E. (2016). Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. The Lancet, 387(10037), 2507-2520.